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Primary cilia are basically signaling hubs, harboring
amongst others the noncanonical WNT, Hedgehog,and
PDGF signaling systems, and their disruption leads to
striking developmental defects. Some ciliopathy-associated
proteins have recently been revealed to be physically or
functionally associated in several distinct groupings, with
limited connections to other crucial biological processes.
Early proteomics studies have also suggested a discrete
repertoire of about 1000 proteins within the organelle (i.e.
<5% of the proteome) that are still in need of organisation
into pathways and networks. Small, relatively isolated sys-
tems are often targeted by systems biology approaches
under the assumption that a limited set of molecules and
interactions will be more tractable for modelling systems.
Cilia are thus ideal organelles for systems biology as they
can be regarded as semi-closed systems being both largely
spatially and biologically separated from many other cellu-
lar structures and processes.
Scientific and technical objectives
Our overall objectives are to establish a paradigm for
studying and modelling complex eukaryotic systems, to
understand how system perturbation contributes to the
modulation of clinical phenotypes, and to provide a better
understanding of ciliary processes in biology and their
associated diseases. Our objectives focus on all critical
components of the systems biology process, namely:
• assay development and application
• data generation, handling and integration
• model building and testing followed by refinement.
We also exploit the models to find new insights into bio-
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